Search research articles
Contact Us
Filters
Showing results (21-30 of 49) with videos related to
Page
of 5
Sort By:
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 5, 2024
Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open-Label, Noninferiority Study (PARASOL Study)
Koichi Yamamoto, Daisuke Yarimizu, Ayano Shimanishi, et al.
Biochemical and Biophysical Research Communications
|
May 29, 2012
Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor
Masaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Clinical and Experimental Nephrology
|
November 18, 2025
Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-Ex
Naoki Kashihara, Seiji Itano, Takaya Nakashima, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 3, 2008
Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence
Fumihiro Sanada, Yoshiaki Taniyama, Junya Azuma, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 9, 2007
Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin
Kazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, et al.
International Journal of Molecular Medicine
|
May 28, 2011
Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model
Mariko Kyutoku, Yoshiaki Taniyama, Naruto Katsuragi, et al.
Atherosclerosis
|
December 17, 2011
Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice
Masaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 7, 2012
Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition
Keita Okayama, Junya Azuma, Norio Dosaka, et al.
Circulation Research
|
August 29, 2009
Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells
Fumihiro Sanada, Yoshiaki Taniyama, Kazuma Iekushi, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 15, 2011
Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway
Kazuma Iekushi, Yoshiaki Taniyama, Hiroshi Kusunoki, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 49) with videos related to
Sort By:
Page
of 5
Journal of Clinical Hypertension (Greenwich, Conn.)
|
December 5, 2024
Efficacy and Safety of Sacubitril/Valsartan Versus Amlodipine in Japanese Patients With Essential Hypertension: A Randomized, Multicenter, Open-Label, Noninferiority Study (PARASOL Study)
Koichi Yamamoto, Daisuke Yarimizu, Ayano Shimanishi, et al.
Biochemical and Biophysical Research Communications
|
May 29, 2012
Inhibition of Lp(a)-induced functional impairment of endothelial cells and endothelial progenitor cells by hepatocyte growth factor
Masaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Clinical and Experimental Nephrology
|
November 18, 2025
Proteinuria reduction as a surrogate endpoint for clinical study of IgA nephropathy in Japanese patients: data from the J-CKD-DB-Ex
Naoki Kashihara, Seiji Itano, Takaya Nakashima, et al.
Hypertension (Dallas, Tex. : 1979)
|
December 3, 2008
Hepatocyte growth factor, but not vascular endothelial growth factor, attenuates angiotensin II-induced endothelial progenitor cell senescence
Fumihiro Sanada, Yoshiaki Taniyama, Junya Azuma, et al.
Hypertension (Dallas, Tex. : 1979)
|
May 9, 2007
Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin
Kazuma Iekushi, Yoshiaki Taniyama, Junya Azuma, et al.
International Journal of Molecular Medicine
|
May 28, 2011
Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model
Mariko Kyutoku, Yoshiaki Taniyama, Naruto Katsuragi, et al.
Atherosclerosis
|
December 17, 2011
Role of serotonin in angiogenesis: induction of angiogenesis by sarpogrelate via endothelial 5-HT1B/Akt/eNOS pathway in diabetic mice
Masaaki Iwabayashi, Yoshiaki Taniyama, Fumihiro Sanada, et al.
Hypertension (Dallas, Tex. : 1979)
|
March 7, 2012
Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition
Keita Okayama, Junya Azuma, Norio Dosaka, et al.
Circulation Research
|
August 29, 2009
Negative action of hepatocyte growth factor/c-Met system on angiotensin II signaling via ligand-dependent epithelial growth factor receptor degradation mechanism in vascular smooth muscle cells
Fumihiro Sanada, Yoshiaki Taniyama, Kazuma Iekushi, et al.
Hypertension (Dallas, Tex. : 1979)
|
June 15, 2011
Hepatocyte growth factor attenuates transforming growth factor-β-angiotensin II crosstalk through inhibition of the PTEN/Akt pathway
Kazuma Iekushi, Yoshiaki Taniyama, Hiroshi Kusunoki, et al.
Page
of 5